The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results?
Open accessAbstract
BACKGROUND: This review of the EUROCARE-4 results attempts to separate out the early and late mortality effects contributing to the widely reported poorer 5-year survival rates for cancer patients in the United Kingdom compared with other European countries for 26 cancer sites. METHODS: Patients diagnosed with cancer in 1996-1999 in 23 European countries were included in the analyses. Comparison of 1-year, 5-year and 5|1-year (i.e. only including those patients who had survived to 1 year) survival estimates between data for England and the 'European average' was undertaken. This analysis was to highlight the relative contribution of early diagnosis, using 1-year survival as a proxy measure, on 5-year survival for the different sites of cancer. Three groups of cancer sites were identified according to whether the survival differences at 1, 5 and 5|1-years were statistically significant. RESULTS AND CONCLUSIONS: Breast cancer showed significantly poorer 1- and 5-year survival estimates in England, but the 5|1-year survival figure was not significantly different. Thus, successful initiatives around awareness and early detection could eradicate the survival gap. In contrast, the 5|1-year survival estimates remained significantly worse for lung, colorectal and prostate cancers, showing that although early detection could make some difference, late effects such as treatment and management of the patients were also influencing long-term outcome differences between England and Europe.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standard cancer patient population for age standardising survival ratios
Corazziari, I., Quinn, M., & Capocaccia, R. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.07.002 · Cited by 589 · cited 1×
“The International Cancer Survival Standard (ICSS; Corazziari et al, 2004) was applied to the EUROCARE-4 data, except for prostate cancer (De Angelis et al, 2009; pp 20).”
MethodWhat if cancer survival in Britain were the same as in Europe: how many deaths are avoidable?
Abdel-Rahman, M., Stockton, D., Rachet, B., Hakulinen, T., & Coleman, M. P. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605401 · Cited by 160
Cited by
De Angelis, R., Sant, M., Coleman, M. P., Francisci, S., Baili, P., Pierannunzio, D., Trama, A., Visser, O., Brenner, H., Ardanaz, E., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70546-1 · Cited by 1,890
Routes to diagnosis for cancer – determining the patient journey using multiple routine data sets
Elliss-Brookes, L., McPhail, S., Ives, A., Greenslade, M., Shelton, J., Hiom, S., & Richards, M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.408 · Cited by 521
Hippisley-Cox, J., & Coupland, C. (2012) · British Journal of General Practice · doi:10.3399/bjgp12x616355 · Cited by 208
Arhi, C. S., Burns, E. M., Bottle, A., Bouras, G., Aylin, P., Ziprin, P., & Darzi, A. (2020) · British Journal of General Practice · doi:10.3399/bjgp20x710441 · Cited by 33
Metadata
- Authors
- Thomson, C. S., & Forman, D.
- Venue
- British Journal of Cancer
- Published
- 2009-12
- Volume
- 101
- Issue
- S2
- Pages
- S102-S109
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2039646338
- Cited by
- 171
- References
- 2
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results? https://app.cochat.ai/papers/10.1038/sj.bjc.6605399
- The paper
- Thomson, C. S., & Forman, D. (2009). Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results? British Journal of Cancer. https://doi.org/10.1038/sj.bjc.6605399
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.